Atlas Trials

Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer

Clinical trial NCT01355562 · WITHDRAWN

Trial details

NCT number
NCT01355562
Sponsor
Loma Linda University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
MelanomaMetastatic Kidney Cancer
Start date
2011-03-01
Primary completion
2012-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.